1 / 11

The G8 & R&D for neglected diseases

The G8 & R&D for neglected diseases. Stewart Tyson DFID. International Financing Facility (IFF) IFF-Immunization French tax proposals What the G8 can do to support R&D.

teige
Download Presentation

The G8 & R&D for neglected diseases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The G8 & R&D for neglected diseases Stewart Tyson DFID

  2. International Financing Facility (IFF) • IFF-Immunization • French tax proposals • What the G8 can do to support R&D

  3. Millennium Project, Africa Commission, Financing for development conference, G8 preparations all highlight need for additional ODA (and action on debt relief and trade) • Need to look for innovative means to raise serious money

  4. The IFF • ‘The big mortgage’ • OECD countries issue bonds to raise money on capital markets –as for large infrastructure projects • Frontload spend to 2015 • OECD countries pay back over long term using future aid budgets • Interest in Europe, none in US • Aim to raise additional $50bn annually

  5. IFF Immunisation • Pilot to test the approach • Likely launch in 4th quarter 2005 • UK, France, Sweden confirmed, also interest in Germany, Italy, Spain, Belgium • UK will fund one third of total • Aim $4bn disbursement over 10 years –will double current spend on immunisation • Pay back $7bn over 20 years –never more than 1% of future aid flows • Prevent 5m child deaths to 2015 • Funds channelled through existing structures

  6. Back to Big IFF • Likely to move forward with a coalition of the willing • Aim $50 bn additional ODA but more likely $15bn annually • Use existing disbursement channels • Big pot of money rather than separate projects such as the IFFIm

  7. Landau proposals • Tobin (currency transfer) tax –little support • Aviation tax –fuel/ticket-support in Europe work underway to look at practicalities and return (likely hundreds of millions euro)

  8. G8 messages • Highlight importance of health- development link (cf CMH calls -$3 bn call for R&D) • Restate commitment to MDGs and need to address financing gap (recent EU commitment to more ODA) • Increase direct investment in R&D for vaccines and drugs • Provide market incentives • ‘HIV, malaria, TB, other parasitic and neglected diseases’ • Invest in strengthening health systems

  9. Looking beyond the G8 • Need new drugs, vaccines, diagnostics • Increase access to and use of existing drugs (ACT, paediatric formulations) • Aim universal access to essential health services • Send signal of predictable market (GAVI-HiB) • Increased direct investment in priority R&D • Use range of approaches(tax breaks on research /sales, APC, prize schemes) • PPP

  10. DFID-Mixed bag of approaches • More ODA-140% increase from 1997-2007 • More research spend (£25m 04/05- £51m 07/08 • Support PPPs (IAVI, MMV, Microbicides but no TB or most neglected diseases as yet) • Better coordination –Global AIDS Vaccine Enterprise (but still at early stage) • Interest in APCs –G7 working group • Vaccine research tax credit • IFF

  11. Challenges • Increased developing country engagement in research • Success of R&D PPPs –increasing $ needs as move to late stage research • Looking beyond HIV/TB/Malaria • Taking forward new models of collaboration and funding • Making health systems work

More Related